How long does one package last?

Package duration depends on the specific product, format and recommended use. Please check the product page for the most accurate guidance.

How should supplements be stored?

Follow the storage instructions listed on the product packaging and detail page. In general, keep products in a dry place away from heat and direct sunlight.

Can I combine products from different categories?

Combination suitability depends on the products involved and your situation. If you need help reviewing a combination, contact support before ordering.

Where can I find ingredient details?

Each product page includes ingredient, category and usage information. If something is unclear, our support team can help you locate the relevant details.

What if a product is out of stock?

Out-of-stock products stay visible so you can compare the catalog. You can contact us to ask about the next restock or similar alternatives.

Mounjaro 15mg | Weight Management Shop

Mounjaro – The Next Generation of Weight Loss

How It Works

Mounjaro (tirzepatide) is not just another weight loss medication — it is the first and only approved molecule that simultaneously activates two key metabolic receptors: GLP-1 and GIP. By engaging both pathways at once, Mounjaro works on multiple fronts: it suppresses appetite, slows gastric emptying, reduces overall food intake, and meaningfully improves insulin sensitivity. This dual-action mechanism sets it apart from anything that came before, delivering a more complete and powerful metabolic response than a single-receptor approach can achieve.

Proven Results

The clinical evidence behind Mounjaro is among the strongest ever recorded for a weight management therapy. In the SURMOUNT-1 trial, participants lost up to 22.5% of their body weight over 72 weeks at the 15 mg dose. Body composition analysis revealed that approximately 75% of the weight lost was pure fat mass — meaning patients shed fat, not muscle. In the 2025 SURMOUNT-5 head-to-head trial, tirzepatide 15 mg delivered an average of 20.2% weight loss compared to 13.7% with semaglutide — a decisive clinical advantage over Ozempic and Wegovy. These are not modest improvements; they represent a genuine shift in what is medically achievable.

Your Journey

Progress with Mounjaro follows a clear and encouraging trajectory. Most patients notice appetite changes within the first few days. By week 12, an average of 8% body weight loss is typically achieved. By week 24, that figure rises to 12–15%. For patients who continue through the full 72-week course, losses of 20–22% are within reach. Treatment begins at a low dose and titrates gradually up to 15 mg via a once-weekly self-injection pen — a simple, discreet routine that fits into everyday life. The most commonly reported side effects are mild-to-moderate gastrointestinal symptoms such as nausea, which typically diminish as the body adjusts.

Why Mounjaro

When results matter, the choice of therapy matters. Mounjaro outperformed semaglutide — the active ingredient in Ozempic and Wegovy — by nearly 7 percentage points in direct clinical comparison. Beyond the numbers on the scale, the quality of weight lost is exceptional: three-quarters of it is fat mass, preserving the lean tissue that supports long-term metabolic health. And the results last: in the SURMOUNT-4 study, 89.5% of patients who continued treatment maintained at least 80% of their lost weight. Patients also experienced meaningful improvements in waist circumference, blood pressure, and broader metabolic health markers. Mounjaro is indicated for adults with obesity or overweight — and for those ready to commit to a new standard of care, it represents the most advanced option available today.

Mounjaro 15mg